Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus
Open Access
- 19 September 2023
- journal article
- research article
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 23 (1) , 1-11
Abstract
Purpose: To determine the population attributable fraction (PAF) of fatty liver disease (FLD) for type 2 diabetes mellitus (T2DM) and compare it to the PAFs of other metabolic abnormalities. Methods: We conducted a 10-year retrospective cohort study of 33,346 individuals in Karamay Central Hospital of Xinjiang. Individuals were followed up for T2DM occurrence based on FBS. The PAFs of FLD were calculated generally and respectively in different sex and age groups. A comparison of the PAF of FLD and that of other metabolic abnormalities, as well as the PAFs of FLD in different groups classified based on age and sex, was performed using Cox regression. Results: During an average follow-up period of 3.71 years, 1486 T2DM were diagnosed. The incidence density of T2DM was 1.2/100 person-years, and cumulative incidence rate was 4456.31/100,000 person-years. Partial PAF (PAFp) of FLD in the entire population was 23.11%. In the male population, PAFp was higher at 30–40 years old. In the female population, it was higher when age ≥ 60 years old. In multivariable Cox regression model, FLD, male sex, age ≥ 45 years old, overweight, hypertriglyceridaemia, and systolic hypertension were independent risk factors for T2DM, with corresponding PAFp of 25.00%, 24.99%, 36.47%, 24.96%, 5.71%, and 6.76%, respectively. Age ≥ 45 years old showed the highest PAFp and adjusted hazard ratio, followed by FLD. Conclusions: FLD contributes more to T2DM incidence than other metabolic disorders. Particular attention should be given to male populations of 30–40 and female populations above 60 for FLD prevention and treatment.Keywords
Funding Information
- Natural Science Foundation of Shannxi Province (2019JM-144)
- Natural Science Foundation of China (81700474)
- Shanghai Pudong Hospital (YJRCJJ201801)
- Natural Science Foundation of Shanghai Municipality (20ZR1450100)
This publication has 28 references indexed in Scilit:
- Hepatokines: linking nonalcoholic fatty liver disease and insulin resistanceNature Reviews Endocrinology, 2017
- Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to ActionDiabetes Care, 2017
- Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes MellitusEndocrine Reviews, 2016
- Endogenous Androgens and Sex Hormone–Binding Globulin in Women and Risk of Metabolic Syndrome and Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2015
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaHepatology, 2015
- 2. Classification and Diagnosis of DiabetesDiabetes Care, 2014
- Estimation of population attributable fraction (PAF) for disease occurrence in a cohort study designStatistics in Medicine, 2010
- Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesThe Lancet, 2004
- Comparison of a Clinical Model, the Oral Glucose Tolerance Test, and Fasting Glucose for Prediction of Type 2 Diabetes Risk in Japanese AmericansDiabetes Care, 2003
- Tests of Glycemia for the Diagnosis of Type 2 Diabetes MellitusAnnals of Internal Medicine, 2002